Evidence map›Paper›PMID 24710577›Full record

ArticleNature reviews. Clinical oncology2014

Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention.

Alexander C J van Akkooi, Alexander M M Eggermont

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature reviews. Clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Updates in adjuvant systemic therapy for melanoma.Journal of surgical oncology · 2019
    Review
  3. Review
  4. Article
  5. MSLT-I-response of clinical trial investigators.Nature reviews. Clinical oncology · 2014
    Article
  6. SLNB in melanoma-DFS a true and cost-effective benefit?Nature reviews. Clinical oncology · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Alexander C J van AkkooiDepartment of Surgical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Alexander M M EggermontCancer Institute, Gustave Roussy Cancer Campus, Grand Paris, 114 rue Édouard Vaillant, 94805 Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymph Node ExcisionSentinel Lymph Node BiopsyFemaleHumansMaleMelanomaSkin Neoplasms

Identifiers

PMID24710577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.